Search Results

There are 77153 results for: content related to: Defining the impact of individual sample variability on routine immunoassay of serum free light chains ( sFLC ) in multiple myeloma

  1. You have free access to this content
    Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

    American Journal of Hematology

    Volume 87, Issue 8, August 2012, Pages: 749–753, Michele Bibas, Maria Paola Trotta, Alessandro Cozzi-Lepri, Patrizia Lorenzini, Carmela Pinnetti, Giuliano Rizzardini, Gioacchino Angarano, Pietro Caramello, Laura Sighinolfi, Claudio Maria Mastroianni, Giovanni Mazzarello, Antonino Di Caro, Cristina Di Giacomo, Antonella d'Arminio Monforte, Andrea Antinori and for the ICONA Foundation Study Group

    Article first published online : 20 JUN 2012, DOI: 10.1002/ajh.23236

  2. Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia

    European Journal of Haematology

    Volume 84, Issue 5, May 2010, Pages: 406–411, Zeynep A. Yegin, Zübeyde N. Özkurt and Münci Yağcı

    Article first published online : 5 JAN 2010, DOI: 10.1111/j.1600-0609.2010.01412.x

  3. Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

    Internal Medicine Journal

    Volume 37, Issue 7, July 2007, Pages: 456–463, K. L. Morris, 1 J. R. Tate, 2 D. Gill, 1 G. Kennedy, 3 J. Wellwood, 4 P. Marlton, 1 R. Bird, 1 A. K. Mills and 1 P. Mollee 1

    Article first published online : 4 JUN 2007, DOI: 10.1111/j.1445-5994.2007.01368.x

  4. You have free access to this content
    Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 63–69, Michelle Furtado, Nimish Shah, Alison Levoguer, Stephen Harding and Simon Rule

    Article first published online : 24 OCT 2012, DOI: 10.1111/bjh.12094

  5. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use

    European Journal of Haematology

    Volume 89, Issue 6, December 2012, Pages: 458–468, Charlotte T. Hansen, Anna-Marie Münster, Lars Nielsen, Per Pedersen and Niels Abildgaard

    Article first published online : 16 OCT 2012, DOI: 10.1111/ejh.12013

  6. Utilisation of sFLC assays – how well do we comply with guidelines?

    International Journal of Laboratory Hematology

    Volume 35, Issue 2, April 2013, Pages: 200–210, D. P. Phillips, D. Talaulikar, C. A. Hawkins and P. E. Hickman

    Article first published online : 8 NOV 2012, DOI: 10.1111/ijlh.12022

  7. You have free access to this content
    Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

    British Journal of Haematology

    Volume 137, Issue 3, May 2007, Pages: 240–243, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Nicoletta Kafasi, Sotirios Sachanas, Tatiana Tzenou, Argiroula Papadogiannis, Zacharoula Galanis, Christina Kalpadakis, Maria Dimou, Elias Kyriakou, Maria K. Angelopoulou, Maria N. Dimopoulou, Marina P. Siakantaris, Evangelia M. Dimitriadou, Styliani I. Kokoris, Panayiotis Panayiotidis and Gerassimos A. Pangalis

    Article first published online : 4 APR 2007, DOI: 10.1111/j.1365-2141.2007.06561.x

  8. You have free access to this content
    Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 144, Issue 2, January 2009, Pages: 217–222, Guy Pratt, Stephen Harding, Roger Holder, Chris Fegan, Chris Pepper, David Oscier, Anne Gardiner, Arthur R. Bradwell and Graham Mead

    Article first published online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07456.x

  9. Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008–2012

    Nephrology

    Volume 19, Issue 7, July 2014, Pages: 432–435, Jasmine Tan, Michael Lam-Po-Tang, Colin A Hutchison and Janak R de Zoysa

    Article first published online : 16 JUN 2014, DOI: 10.1111/nep.12267

  10. Light-chain removal by plasmapheresis in myeloma-associated renal failure

    Transfusion

    Volume 47, Issue 3, March 2007, Pages: 511–514, Christine Cserti, Richard Haspel, Christopher Stowell and Walter Dzik

    Article first published online : 21 FEB 2007, DOI: 10.1111/j.1537-2995.2006.01143.x

  11. Time to redefine Myeloma

    British Journal of Haematology

    Volume 171, Issue 1, October 2015, Pages: 1–10, Guy Pratt, Stella Bowcock, Andrew Chantry, Gordon Cook, Graham Jackson, Maggie Lai, Eric Low, Nicola Mulholland, Roger Owen, Neil Rabin, Karthik Ramasamy, John A Snowden, Matthew Streetly, Ashutosh Wechalekar, Kwee Yong and Jenny Bird

    Article first published online : 27 JUL 2015, DOI: 10.1111/bjh.13620

  12. Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents

    Hematological Oncology

    Volume 30, Issue 3, September 2012, Pages: 156–162, Sherry Mori, Brooke S Crawford, Julianna VF Roddy, Gary Phillips, Pat Elder, Craig C Hofmeister, Yvonne Efebera and Don M Benson Jr

    Article first published online : 26 OCT 2011, DOI: 10.1002/hon.1019

  13. Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR

    European Journal of Haematology

    Volume 93, Issue 5, November 2014, Pages: 407–413, Charlotte T. Hansen, Per T. Pedersen, Lars C. Nielsen and Niels Abildgaard

    Article first published online : 14 JUN 2014, DOI: 10.1111/ejh.12376

  14. Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents

    Hematological Oncology

    Volume 31, Issue 2, June 2013, Pages: 96–102, Dimitrios Maltezas, Meletios A. Dimopoulos, Irene Katodritou, Panagiotis Repousis, Anastasia Pouli, Evangelos Terpos, Panayiotis Panayiotidis, Sossana Delimpasi, Evridiki Michalis, Konstantinos Anargyrou, Maria Gavriatopoulou, Aikaterini Stefanoudaki, Tatiana Tzenou, Efstathios Koulieris, Sotiris Sachanas, Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Gerassimos A. Pangalis and Marie-Christine Kyrtsonis

    Article first published online : 7 SEP 2012, DOI: 10.1002/hon.2026

  15. You have free access to this content
    Serum free light chain analysis

    American Journal of Hematology

    Volume 85, Issue 10, October 2010, Pages: 787–790, Matthew S. Davids, Mandakolathur R. Murali and David J. Kuter

    Article first published online : 6 JUL 2010, DOI: 10.1002/ajh.21815

  16. You have free access to this content
    Candida albicans Sfl2, a temperature-induced transcriptional regulator, is required for virulence in a murine gastrointestinal infection model

    FEMS Yeast Research

    Volume 11, Issue 2, March 2011, Pages: 209–222, Wenji Song, Huafeng Wang and Jiangye Chen

    Article first published online : 14 JAN 2011, DOI: 10.1111/j.1567-1364.2010.00710.x

  17. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment

    American Journal of Hematology

    Volume 90, Issue 7, July 2015, Pages: 647–652, Beatrice Anna Zannetti, Elena Zamagni, Marisa Santostefano, Lucia Barbara De Sanctis, Paola Tacchetti, Elena Mancini, Lucia Pantani, Annamaria Brioli, Raffaella Rizzo, Katia Mancuso, Serena Rocchi, Annalisa Pezzi, Enrica Borsi, Carolina Terragna, Giulia Marzocchi, Antonio Santoro and Michele Cavo

    Article first published online : 22 JUN 2015, DOI: 10.1002/ajh.24035

  18. You have free access to this content
    Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients

    American Journal of Hematology

    Volume 86, Issue 6, June 2011, Pages: 475–478, Brendan M. Weiss, Alex Minter, Jude Abadie, Robin Howard, Joao Ascencao, Geraldine P. Schechter, Michael Kuehl and Ola Landgren

    Article first published online : 4 MAY 2011, DOI: 10.1002/ajh.22025

  19. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma

    European Journal of Haematology

    Volume 90, Issue 2, February 2013, Pages: 134–141, Kan-ichi Iwama, Dai Chihara, Kenji Tsuda, Tomotaka Ugai, Hiroyuki Sugihara, Yuhki Nishida, Masayuki Yamakura, Masami Takeuchi and Kosei Matsue

    Article first published online : 7 JAN 2013, DOI: 10.1111/ejh.12050

  20. You have free access to this content
    The evolving use of serum free light chain assays in haematology

    British Journal of Haematology

    Volume 141, Issue 4, May 2008, Pages: 413–422, Guy Pratt

    Article first published online : 3 MAR 2008, DOI: 10.1111/j.1365-2141.2008.07079.x